Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
$5.44 +0.02 (0.37%)
As of 03/22/2023 14:44:51 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.